Introduction
One of the most common pitfalls when launching a CBD brand with Chinese manufacturing is packaging and labeling compliance. Beautiful packaging that violates regulatory requirements creates costly problems — product holds at customs, regulatory warnings, forced relabeling, or worst of all, product destruction.
CBD packaging and labeling requirements differ significantly across markets. What satisfies US FDA requirements may violate UK FSA rules. What works for EU Novel Food regulations may omit required US disclosures. This guide covers the key regulatory frameworks and how to navigate them when manufacturing in China.
—
US FDA Requirements
Hemp-Derived CBD Products
The FDA regulates CBD under the Federal Food, Drug, and Cosmetic Act (FD&C Act). Key labeling requirements:
Mandatory label elements:
- Product identity (what it is)
- Net quantity of contents
- Manufacturer/distributor name and address
- Ingredient list in descending order of predominance
- Nutrition facts (for dietary supplements)
CBD-specific considerations:
- FDA has not approved CBD as a dietary supplement or food additive
- Companies marketing CBD products do so at regulatory risk
- Claims about treating diseases are prohibited (drug claims)
- Structure/function claims require standard disclaimer
Current FDA enforcement environment:
- CBD in food and supplements remains technically illegal at federal level
- Enforcement is product- and claim-specific
- Companies proceed under risk, not clearance
State-Level Requirements
Individual US states may impose additional requirements:
- Warning label requirements (Proposition 65 in California)
- THC disclosure requirements
- Child-resistant packaging mandates
- Specific warning text requirements
—
European Union Requirements
Novel Food Regulation
CBD extracts produced from hemp are classified as Novel Foods under EU regulation, requiring:
- Pre-market safety authorization (currently not granted for most CBD forms)
- Novel Food application dossiers for products entering the market
Current status: Most CBD food and supplement products in the EU are technically non-compliant with Novel Food regulation. The industry operates in regulatory limbo as EFSA evaluates safety dossiers.
EU Labeling Requirements
For compliant products, EU labeling requires:
- Product name and description
- List of ingredients
- Quantity of certain ingredients
- Net quantity
- Storage conditions
- Name and address of food business operator
- Country of origin
- Nutritional declaration
- Instructions for use
- THC warning (required for hemp-derived products)
THC limit: 0.2% in finished food products.
THC Disclosure
All hemp-derived products entering the EU must include THC content disclosure on labels.
—
United Kingdom Requirements
FSA Advisory List Process
Post-Brexit, the UK operates its own CBD food supplement regulatory framework:
- CBD food supplement products must submit an application to the FSA
- Products on the “advisory list” of novel foods can remain on market
- Applications require detailed safety dossiers
UK Labeling Requirements
Current UK requirements for CBD food supplements:
- CBD content must be stated
- Recommended portion size
- Do not exceed recommended daily intake
- Do not use if pregnant or breastfeeding (unless safe)
- Keep out of reach of children
- THC content disclosure (mandatory for hemp-derived products)
- THC limit: 1mg per container in food products
—
Working With Chinese Manufacturers on Compliance
Who Is Responsible?
The legal responsibility for compliant labeling falls on the brand/company selling the product — not the manufacturer. However:
- Manufacturers familiar with export markets can advise on requirements
- Always verify compliance requirements independently
- Have label artwork reviewed by regulatory counsel for your specific markets
Information to Provide Your Manufacturer
When working with Chinese manufacturers, clearly communicate:
1. Destination market(s) for the product
2. All applicable regulatory frameworks
3. Specific label claims and statements required
4. Language requirements (labels must be in local language for many markets)
5. Any testing or documentation needed to support label claims
Label Artwork Process
Typical workflow:
1. Manufacturer provides label template with regulatory text
2. Brand provides artwork and logo placement
3. Manufacturer produces label proofs
4. Brand reviews and approves proofs
5. Regulatory counsel reviews for compliance
6. Final approval and production
—
Common Labeling Mistakes to Avoid
Mistakes That Cause Customs Problems
- Missing required warnings or disclosures
- Incorrect THC content declarations
- Misleading potency claims
- Missing batch numbers or lot codes
- Non-compliant health claims
- Labels in wrong language for destination market
Preventing Problems
- Verify all regulatory requirements before labeling design
- Include compliance review in production approval process
- Maintain documentation of label approval and regulatory review
- Keep label artwork on file with version control
—
Conclusion
CBD packaging and labeling compliance requires careful attention to the regulatory requirements of your target markets. Work closely with your Chinese manufacturer — they have experience with international compliance requirements — but verify everything independently with regulatory counsel for your specific markets.
Compliant labeling is non-negotiable. The cost of non-compliance is far higher than the investment in getting it right from the start.
Table of Contents
